Samuel D. Gross Professor and Chair of Surgery, Thomas Jefferson University
General Surgery
Dr. Charles J. Yeo, MD
|
|
Give Review
Charles works in the field of General Surgery. He went to Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical college. Johns Hopkins University School of Medicine has a rank of 3 in research and a 29 in primary care He received awards:"Philadelphia Magazine", "America's Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification", "Super Doctor" and "Fellow (FACS)". Doctor Charles J. Yeo, MD is a published MD as well. He has 101 publications published. The latest was: Modified Appleby Procedure with Arterial Reconstruction for Locally Advanced Pancreatic Adenocarcinoma: A Literature Review and Report of Three Unusual Cases. He is registered with Medicare.
Publications
- Modified Appleby Procedure with Arterial Reconstruction for Locally Advanced Pancreatic AdenoCarcinoma: A Literature Review and Report of Three Unusual Cases.
- Osteopontin (OPN) Isoforms, Diabetes, Obesity, and Cancer; What Is One Got to Do with the Other? A New Role for OPN.
- MUC1 Promoter-Driven DTA as a Targeted Therapeutic Strategy against Pancreatic Cancer.
- Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs.
- Francis Daniels Moore: one of the brightest minds in the surgical field.
- Vivien Thomas: master craftsman, gifted teacher, and unsung hero.
- Evaluation of the validity of medical students' self-assessments of proficiency in clinical simulations.
- Dr. Mary Edwards Walker: years ahead of her time.
- MCT4 Defines a Glycolytic Subtype of Pancreatic Cancer with Poor Prognosis and Unique Metabolic Dependencies.
- Robert edward gross (1905-1988): ligation of a patent Ductus arteriosus and the birth of a specialty.
- PARP Inhibitors for Chemoprevention-Letter.
- Incidence and Severity of Pancreatogenic Diabetes After Pancreatic Resection.
- Ambroise paré (1510 to 1590): a surgeon centuries ahead of his time.
- Francis f. Maury, m.d. (1840 to 1879): an often forgotten pioneer in early american surgery.
- Roscoe reid graham (1890 to 1948): a canadian pioneer in general surgery.
- dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic Cancer: A dual-institutional follow-up with the RTOG 9704 trial.
- Complex cystic lesions in the liver causing Abdominal pain.
- Intraoperative Pancreatoscopy: A Valuable Tool for Pancreatic Surgeons?
- Non-neoplastic Epithelial Cysts of the Pancreas: A Rare, Benign Entity.
- Mary h. Gibbon: teamwork of the heart.
- Does Resident Experience Affect Outcomes in Complex Abdominal Surgery? Pancreaticoduodenectomy as an Example.
- Edoardo Bassini (1844-1924): Father of Modern-day Hernia Surgery.
- Overexpressing TNF-Alpha in Pancreatic Ductal Adenocarcinoma Cells and Fibroblasts Modifies Cell Survival and Reduces Fatty Acid Synthesis via Downregulation of Sterol...
- Abdominal Pain and a Biliary Abnormality.
- Samuel d. Gross, m.d. (1805-1884): an innovator, even in death.
- Clinical Significance of Serum COL6A3 in Pancreatic Ductal Adenocarcinoma.
- Mitoxantrone Targets Human Ubiquitin-Specific Peptidase 11 (USP11) and Is a Potent Inhibitor of Pancreatic Cancer Cell Survival.
- Differential Expression of Cytochrome P450 Omega-hydroxylase Isoforms and Their Association with Clinicopathological Features in Pancreatic Ductal Adenocarcinoma.
- HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic Cancer.
- Chevalier Jackson, M.D. (1865-1958): Il ne se repose jamais.
- Preoperative Imaging for Resectable Periampullary Cancer: Clinicopathologic Implications of Reported Radiographic Findings.
- Acinar Cell Cystadenoma of the Pancreas: Report of Three Cases and Literature Review.
- Circadian gene expression and clinicopathologic correlates in pancreatic Cancer.
- Defining treatment and outcomes of hepaticojejunostomy failure following Pancreaticoduodenectomy.
- John Chalmers DaCosta (1863-1933): Restoration of the Old Operating Table.
- Serum blood urea nitrogen and serum albumin on the first postoperative day predict Pancreatic fistula and major complications after Pancreaticoduodenectomy.
- A dual-institution randomized controlled trial of remnant closure after distal pancreatectomy: does the addition of a falciform patch and fibrin glue improve outcomes?
- William edwards ladd, m.d. (1880-1967): the description of his bands.
- Emil Theodor Kocher, M.D., and his Nobel Prize (1841-1917).
- John Y. Templeton III: Pioneer of Modern Cardiothoracic Surgery.
- Combined hepatic arterial embolization and hepatic ablation for unresectable Colorectal metastases to the liver.
- HuR's post-transcriptional regulation of Death Receptor 5 in pancreatic Cancer cells.
- Diagnostic, prognostic, and predictive biomarkers in pancreatic Cancer.
- Christian albert theodor billroth, m.d., founding father of Abdominal surgery (1829-1894).
- Theodor billroth and his musical life.
- IntraDuctal Papillary Mucinous Neoplasm (IPMN) with Extra-Pancreatic Mucin: A Case Series and Review of the Literature.
- Sarcoid-Reaction Mimicking Metastatic Malignant HepatopancreatoBiliary Tumors: Report of Two Cases and Review of the Literature.
- Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic Ductal adenocarcinoma.
- Neuroendocrine tumors of the pancreas.
- Extended Follow-Up and Outcomes of Patients Undergoing Pancreaticoduodenectomy for Nonmalignant Disease.
- The gross clinic, the agnew clinic, and the listerian revolution.
- Robert milton zollinger, m.d., teacher, surgeon, soldier, and farmer.
- Surgical Apgar Score Predicts Perioperative Morbidity in Patients Undergoing Pancreaticoduodenectomy at a High-Volume Center.
- Molecular Profiling of Synchronous and Metachronous Cancers of the Pancreas Reveal Molecular Mimicry Between Samples from the Same Patient.
- Perioperative Surgical Care Bundle Reduces Pancreaticoduodenectomy Wound Infections.
- John h. Gibbon, jr., m.d.: surgical innovator, pioneer, and inspiration.
- Dunking pancreaticojejunostomy versus Duct-to-mucosa anastomosis.
- Subject Review: Pancreatic Ductal Adenocarcinoma in the Setting of Mutations in the Cystic Fibrosis Transmembrane ConDuctance Regulator Gene: Case Report and Review of...
- Angiotensin II type 2 receptor blockade inhibits fatty acid synthase production through activation of AMP-activated protein kinase in pancreatic Cancer cells.
- Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic Cancer.
- Tribute to John L. Cameron, M.D.
- George McClellan, M.D.: The Man, the Surgeon, the Founder.
- Giant splenic artery pseudoAneurysm.
- Reoperative Completion Pancreatectomy for Suspected Malignant Disease of the Pancreas.
- Thomas Dent Mütter: the humble narrative of a surgeon, teacher, and curious collector.
- Sir william ernest miles.
- William Williams Keen, MD: 'Marshall' of American Surgery and Pioneer of Neurosurgery.
- The Influence of Prognostic Factors and Adjuvant Chemoradiation on Survival After Pancreaticoduodenectomy for Ampullary Carcinoma.
- The Novel Triad of Dorsal Agenesis of the Pancreas with Concurrent Pancreatic Ductal Adenocarcinoma and Nonalcoholic Chronic Calcific Pancreatitis: A Case Series and R...
- Oncologic efficacy is not compromised, and may be improved with minimally invasive esophagectomy.
- Is gastrectomy safe in the elderly? A single institution review.
- A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenoCarcinoma. A Phase II trial of safety, ef...
- Remembering Semmelweis: hand hygiene and its importance on today's clinical practice.
- The past, present, and future of biomarkers: a need for molecular beacons for the clinical management of pancreatic Cancer.
- CanScript, an 18-Base pair DNA sequence, boosts tumor cell-specific promoter activity: implications for targeted gene therapy.
- Involvement of osteopontin in the matrix-degrading and proangiogenic changes mediated by nicotine in pancreatic Cancer cells.
- Evaluation of the use of patient-focused simulation for student assessment in a surgery clerkship.
- Implications of enhancer of zeste homologue 2 expression in pancreatic Ductal adenocarcinoma.
- HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic Ductal adenocarcinoma patients.
- Preoperative mechanical bowel preparation does not offer a benefit for patients who undergo Pancreaticoduodenectomy.
- Pancreatic surgery 101: drain, no drain, early drain removal, or late drain removal. What are the data? Where do we go from here?
- InDuction of monocyte chemoattractant protein-1 by nicotine in pancreatic Ductal adenocarcinoma cells: role of osteopontin.
- Blocking angiotensin II Type 1 receptor triggers apoptotic cell death in human pancreatic Cancer cells.
- Optimal technical management of stump closure following distal pancreatectomy: a retrospective review of 215 cases.
- Periampullary and duodenal neoplasms in neurofibromatosis type 1: two cases and an updated 20-year review of the literature yielding 76 cases.
- Preoperative drainage in pancreatic Cancer.
- Jefferson Medical College of Thomas Jefferson University, the Department of Surgery: from past to present.
- Reconstruction following the pylorus preserving Whipple resection: PJ, HJ, and DJ.
- Toward improving uniformity and standardization in the reporting of Pancreatic anastomoses: a new classification system by the International Study Group of Pancreatic ...
- pp32 (ANP32A) expression inhibits pancreatic Cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs.
- Angiotensin II regulates the expression of monocyte chemoattractant protein-1 in pancreatic Cancer cells.
- Margin positive pancreaticoduodenectomy is superior to palliative bypass in locally advanced pancreatic Ductal adenocarcinoma.
- Reply to "Gallbladder Cancer: The Role of Laparosco"
- Assessment of "gene-environment" interaction in cases of familial and sporadic pancreatic Cancer.
- Expression of a prometastatic splice variant of osteopontin, OPNC, in human pancreatic Ductal adenocarcinoma.
- InDuction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic Ductal adenocarcinoma cells.
- Acinar Cell Carcinoma With a Prominent IntraDuctal Growth Pattern: Case Report With Review of the Literature.
- Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival.
- The role of HuR in gemcitabine efficacy in pancreatic Cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase.
- Implementation of a critical pathway for distal pancreatectomy at an academic institution.
Schools
Johns Hopkins University School Of Medicine
The Johns Hopkins Hospital
Princeton University
Research Fellowship Downstate Medical Center SUNY
Surgical Registrar Royal College Of Surgeons In Ireland Laurences Hospital Professorial Unit
Procedures Preformed
- Adrenalectomy
- Cholecystectomy with Robotic Assistance
- Colectomy
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- View All
Conditions Treated
- Abdominal Pain
- Adrenal Gland Cancer
- Atelectasis
- Bile Duct Cancer
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- Philadelphia Magazine
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACS)
Education
-
Johns Hopkins University -
SUNY Health Science Center at Brooklyn -
Johns Hopkins University School of Medicine
Hospital
-
Thomas Jefferson University Hospital
Drug Facts
| NPI NUMBER | 1669492336 | |
| NPPES Provider LastName | YEO | |
| NPPES Provider FirstName | CHARLES | |
| NPPES Provider ZIPCode | 191075563 | |
| NPPES Provider State | PA | |
| Specialty Description | General Surgery | |
| Total Claim Count | 26.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1669492336 |
| Last Name Of The Provider | YEO |
| First Name Of The Provider | CHARLES |
| View All |
Similar Doctors
|
Dr. Andrew C. Raissis, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip O. Eck, MD |
|
|
Dr. Blake D. Babcock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dale M. Mandel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kamran Khanmoradi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul B. Bolno, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sharven Taghavi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Madalyn G. Peters, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas R. Murken, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nazish K. Hashmi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Basit K. Achakzai, MD |
|
|
Dr. Sunil S. Karhadkar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Migaly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Judy D. Ross, MD |
|
Dr. Dahlia M. Sataloff, MD
This Doctor is OpenDoctor Recommended.
|